Ledger.Open graph →
SEC Form D · filed December 22, 2020

Faze Medicines, Inc

Offering
$81.0M
Sold
$30.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Ed Freedman · Cambridge, MAExec · DirectorCharles Homcy · South San Francisco, CADirectorCary Pfeffer · Cambridge, MAExec · DirectorRobert Tepper · Cambridge, MADirectorCary Pfeffer · Boston, MAExec · DirectorEd Freedman · Cambridge, MAExec · DirectorRobert Tepper · Newton, MADirectorCharles Homcy · South San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗